88
Views
0
CrossRef citations to date
0
Altmetric
Review

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib

&
Pages 81-89 | Published online: 18 Sep 2014